BRIEF-Citius pharmaceuticals receives "fast track" designation by FDA for mino-lok™ investigational trial
October 31, 2017 at 08:08 AM EDT
* Citius Pharmaceuticals, Inc. Receives "fast track" designation by FDA for mino-lok™ investigational trial Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)
